Data as of 2026-10-17US market
Summary
Screened 12 undervalued US stocks on October 17, 2026; ADBE, NKE, PYPL, CVS, and LEN offer the strongest fundamental resilience, margin expansion, and valuation discounts for a 6 to 18 month horizon.
Screening weights
Fundamental improvement30%
Candidate comparison
| Rank | Ticker | Sector | 3M return | Revenue YoY | OPM Δ | FCF | Score |
|---|
| 1 | Adobe Inc. | Software | -18.5% | +10.6% | +1.5%p | Positive | 9.6 |
| 2 | NIKE, Inc. | Consumer | -15.2% | +1.1% | +0.4%p | Positive | 9.2 |
| 3 | PayPal Holdings | Fintech | -8.1% | +8.2% | +1.1%p | Positive | 9.0 |
| 4 | CVS Health | Healthcare | -5.9% | +7.3% | +1.0%p | Positive | 8.8 |
| 5 | Lennar Corporation | Homebuilding | -12.4% | +7.9% | +0.2%p | Positive | 8.7 |
| 6 | Autodesk | Design Software | -3.5% | +16.0% | +2.0%p | Positive | 8.5 |
| 7 | Western Digital | Storage Hardware | -6.1% | +23.8% | +4.3%p | Positive | 8.4 |
| 8 | Lululemon Athletica | Consumer | -19.2% | +7.3% | +0.4%p | Positive | 8.2 |
| 9 | Salesforce | Cloud CRM | -10.8% | +8.4% | +3.2%p | Positive | 8.0 |
| 10 | J.B. Hunt Transport | Industrials | -12.2% | +4.8% | +0.3%p | Positive | 7.8 |
| 11 | Starbucks | Restaurants | -3.5% | +2.2% | +0.4%p | Positive | 7.5 |
| 12 | Intel | Semiconductors | -14.1% | +7.5% | +0.6%p | Positive | 6.5 |
Screened names (observations)
Observation
Exceptional valuation and cash-flow disconnect at $242-$246 multi-year lows, down 47% off peak amid broader tech pullbacks. Trades at an EV/FCF of ~8.9x (lower than 99% of its 10-year historical trading band). Generates $2.2B+ in quarterly free cash flow ($8B+ annual run-rate) with 46% Non-GAAP operating margin and $25B active share repurchases retiring 29M shares YoY.
Catalysts to watch
- Commercial adoption of next-gen Firefly video models and enterprise GenStudio post-Adobe MAX
- Oversold technical mean-reversion toward 20-day moving average
- Aggressive multi-billion dollar open-market share repurchases
Risks
- Generative AI design pricing competition
- Enterprise creative sales cycle elongation
Framework exit signals
- Digital Media net new ARR growth falls below +8% YoY
- GAAP operating margin contracts below 32%
Metrics to watch
- Digital Media net new ARR
- Enterprise GenStudio customer adoption count
Observation
High-conviction turnaround setup following the official start of 32-year veteran Elliott Hill as CEO on October 14. Trading at a multi-decade low multiple (~18x forward P/E, -60% off peak), Nike cleared negative guidance overhang in Q1. Realignment to core performance sports innovation, wholesale retail reconciliations, and $3.8B in annual FCF provide a resilient floor.
Catalysts to watch
- Elliott Hill officially in place as CEO driving comprehensive strategic and product reboot
- Restoration of wholesale retail partner shelf-space across Foot Locker and specialty running doors
- Inventory normalization paving the path for gross margin recovery in 2027
Risks
- Greater China consumer spending recovery friction
- Category competition from On and Hoka in performance running
Framework exit signals
- North American wholesale order book contracts >8% YoY
- Gross margin drops below 42.0%
Metrics to watch
- Wholesale vs Direct-to-Consumer order velocity
- Gross margin trajectory (%p)
Observation
Trading at ~12.5x Forward P/E despite sustained operational turnaround: TMD growth +8.2% YoY, Fastlane guest checkout conversion lifting conversions by 80%, and $5B+ in buybacks retiring >7% of the float annually heading into peak Q4 holiday e-commerce shopping.
Catalysts to watch
- Fastlane enterprise scaling across Shopify and major platforms accelerating into holiday retail season
- Venmo monetization via debit and merchant pay
- Accelerating EPS accretion from aggressive share retirement
Risks
- Competition from Stripe and Apple Pay
- Macro e-commerce consumer spending softness
Framework exit signals
- TMD dollar growth turns negative YoY
- Non-GAAP OPM falls below 16.5%
Metrics to watch
- TMD growth YoY
- Active accounts transaction volume
Observation
High-yield turnaround compounder trading at ~11.0x forward P/E with a 3.0% dividend yield. Executive leadership transition appointing David Joyner as CEO provides immediate operational focus, Q2 Medical Benefit Ratio improved 250 bps YoY to 87.4%, and full-year CFFO is reaffirmed at $11.5B+.
Catalysts to watch
- David Joyner CEO leadership restructuring driving healthcare operations execution
- Multi-year Medicare Advantage margin recovery pathway
- MinuteClinic and care delivery volume expansion
Risks
- Medical cost utilization spikes in late 2026
- PBM regulatory scrutiny
Framework exit signals
- MBR exceeds 89.5% for two consecutive quarters
- Operating margins compress >100 bps YoY
Metrics to watch
- Health Care Benefits MBR
- Annual operating cash flows
Observation
Deep value dislocation at ~9.3x P/E with zero net homebuilding debt and $3.5B+ in cash reserves. Benefiting from mortgage rate easing following Fed rate cuts and secular structural US housing shortages, Lennar's disciplined land-light execution provides defensive downside safety.
Catalysts to watch
- Mortgage rate stabilization unlocking buyer contract closings into Q4
- Consistent $250M quarterly share repurchase program
- Targeted mortgage rate buydowns sustaining high delivery volume
Risks
- Resurgent Treasury yield volatility delaying fall homebuyer traffic
- Gross margin pressure from financing incentives
Framework exit signals
- Homebuilding gross margin drops below 20.0%
- Quarterly net deliveries fall >10% YoY
Metrics to watch
- Homebuilding gross margin
- Quarterly new orders count
AlphaSignal Research: Top 5 Undervalued US Common Stocks (Oct 17, 2026)
1. Executive Summary
Following a sharp weekly tech pullback led by semiconductor and cloud infrastructure consolidation, institutional capital is aggressively rotating into high-quality, cash-generative market leaders trading at compressed multiples. By screening 12 US common stocks characterized by lagging 3-month price returns despite expanding quarterly operating profitability, steady revenue growth, and robust free cash flow, we finalized the Top 5 Undervalued US Stocks offering asymmetric risk/reward over a 6 to 18 month horizon.
2. Candidate Comparison Table
- ADBE (Score: 9.6) | Software | 3M Return: -18.5% | Rev Growth: +10.6% | OPM Change: +1.5%p | FCF: Positive
- NKE (Score: 9.2) | Consumer | 3M Return: -15.2% | Rev Growth: +1.1% | OPM Change: +0.4%p | FCF: Positive
- PYPL (Score: 9.0) | FinTech | 3M Return: -8.1% | Rev Growth: +8.2% | OPM Change: +1.1%p | FCF: Positive
- CVS (Score: 8.8) | Healthcare | 3M Return: -5.9% | Rev Growth: +7.3% | OPM Change: +1.0%p | FCF: Positive
- LEN (Score: 8.7) | Homebuilding | 3M Return: -12.4% | Rev Growth: +7.9% | OPM Change: +0.2%p | FCF: Positive
- ADSK (Score: 8.5) | 7. WDC (Score: 8.4) | 8. LULU (Score: 8.2) | 9. CRM (Score: 8.0) | 10. JBHT (Score: 7.8) | 11. SBUX (Score: 7.5) | 12. INTC (Score: 6.5)
3. Top 5 Detailed Breakdown
- ADBE (9.6): Extreme cash-flow dislocation at $242-$246 multi-year lows (EV/FCF ~8.9x, 10-year percentile <1%); post-MAX commercial Firefly ramp, generates $2.2B+ quarterly FCF ($8B+ annual run-rate) with 46% Non-GAAP OPM and active $25B buybacks retiring 29M shares YoY.
- NKE (9.2): Multi-decade valuation low (~18x P/E, -60% off peak); veteran CEO Elliott Hill officially began tenure on Oct 14 driving core sport innovation and wholesale shelf-space recovery, backed by $3.8B in annual FCF.
- PYPL (9.0): P/E ~12.5x, TMD +8.2% YoY turnaround, Fastlane guest checkout conversion lifting conversions by 80%, retiring >7% of shares annually via $5B+ repurchases heading into Q4 holidays.
- CVS (8.8): P/E ~11.0x, 3.0% dividend yield, David Joyner appointed CEO to accelerate operational healthcare restructuring, Q2 MBR improved 250 bps YoY to 87.4%, CFFO guidance reaffirmed at $11.5B+.
- LEN (8.7): P/E ~9.3x with zero net homebuilding debt and $3.5B+ cash reserves; easing mortgage rates and chronic US housing shortages provide strong downside floor.
4. Conclusion
- Highest Conviction: ADBE
- Best Turnaround Catalyst: NKE
- Best Cash-Flow Compounder: PYPL
- Best Management Catalyst: CVS
- Best Balance Sheet & Value: LEN
- Watchlist: ADSK, WDC, LULU, CRM